bpc-157 multiple sclerosis trial Join me on today's episode of The Doctor's Farmacy as Dr. Edwin Lee and I explore the transformative potential of peptides. We share insights on BPC 157, a peptide known for its remarkable ability to What is Multiple Sclerosis? -

Many patients experience mobility improvements they thought were once impossible without major surgery

TB-500 supports systemic cell migration and broader tissue regeneration

Quick answer: BPC-157 acts locally to drive angiogenesis and site-directed tissue repair, while TB-500 (thymosin beta-4) acts systemically to promote cell migration

Clear notes, correct codes, and lab proof keep claims moving and revenue steady

"Physicians should have every available arrow in the quiver to treat illness and, because of the FDA's inaction, they don't," said Lee Rosebush, who helped bring the lawsuit against FDA and represents a group of large compounding pharmacies